SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair (GZTR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BWAC who wrote (2514)2/16/1999 8:18:00 PM
From: Joe Dancy  Read Replies (1) of 2553
 
For what it is worth, maybe not much, Michael Murphy of the Cal Tech letter recently did an interview with SI's Mark Johnson, and Murphy was bullish on biotechs in 1999. He thought that the number of drugs approved would increase substantially from last year, some companies would turn a profit that to date have not, and that the FDA was very in tune with getting drugs moved through the approval process.

FWIW, Johnson's interview with Murphy is at audioinvestor.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News